Standard BioTools (LAB)

• Market cap: $348M
• 1 day: -2.12%
• 5 days: -22.13%
• 1 month: -12.11%
• 3 months: -4.6%
• 6 months: -38.78%
• Year to date: -30.1%
• 1 year: -15.46%
• 5 years: -85.5%
• 10 years: -91.12%
• Sector: Healthcare
• Industry: Medical Devices

About: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Employees: 389